• contact
  • |
  • site map
  • |
  • careers
 
  • Home
  • About Us
    • Overview
    • Executive Team
    • Board of Directors
    • Collaborations
    • Mission
    • Corporate History
    • Advisors
  • Technology
    • Overview
    • Innovation @ Chikujee
    • Focused Diversification
    • Drug Development
    • Advantages
    • Personalized Healthcare
    • Clinical Trials
  • Products
    • Overview
    • Autism
    • Targeted Therapeutics
    • Biomarker Monitoring
    • Personalized Products
  • Investors
    • Overview
    • Investment Highlights
    • IP Strategy
    • Business Strategy
    • Investor Contacts
  • News & Events
    • News
    • Events
    • Corporate Fact Sheet
    • Corporate Library
    • Media Contacts
    • Join Mailing List
  • Careers
    • Overview
    • Culture
    • Diversity
    • Job Opportunities

Home › Overview › Personalized Healthcare
  • Overview
  • Innovation @ Chikujee
  • Focused Diversification
  • Efficient Drug Development
  • Technology Advantages
  • Personalized Healthcare
  • Clinical Trials


 

Chikujee Technology

 

THE Aayush personalized Health care PLATFORM

 Personalized Healthcare Portfolio

Seamless integration of convergent technologies- leading the path to Personalized Healthcare

 

Multifunctional nanoparticles is a key strategic advantage for our company in achieving our main goal of advancing Personalized Healthcare, an approach that seeks to tailor treatments to specific cancer treatments based on seamless integration of latest scientific understanding of disease at the molecular level and innovative nanotechnology.

The technological integration of detection, targeted therapeutics and clinical monitoring of biomarkers enables seamless collaboration along the whole value chain, from early detection to treatment. This is particularly important since personalized healthcare starts early in the disease management process.

Our completed proof of concept studies in animal models, using this approach already shown clear benefits:

  • An ultrasensitive in vitro detection of Breast and ovarian cancer cells  
  • Simultaneous detection of multiple biomarkers in one test
  • To  identify and use diagnostic tests to characterize or select patient groups for clinical trials
  • To identify those patients who are most likely to benefit
  • Biomarker specific targeting of drug to the cancer site (Zip-code specificity)
  • Clinical monitoring of the treatment efficacy by patient-friendly non-invasive methods
  • Foundation for all the components of personalized product for cancer treatment.

© 2012 Chikujee Therapeutics | Privacy Policy | Terms of Use | Join Mailing List